CD274 and head and neck squamous cell carcinoma: This is a unique prospective study that aimed to assess the prognostic impact of immune biomarkers, including TIL and PD-L1 expression, alone or in combination, in HNSCC patients with loco-regionally advanced tumors undergoing definitive radiotherapy and/or radiochemotherapy.